Ending Disparities in Kidney Disease in Virginia & Metro DC
About This Event
A Leadership Summit Hosted by the National Kidney Foundation!
It is estimated that 1,000,000 adults in Virginia are living with chronic kidney disease (CKD). Of these individuals, approximately 900,000 remain undiagnosed. The majority of people at risk for CKD do not receive the recommended testing. African Americans, Hispanics, Native Americans, and other communities of color are disproportionately affected by CKD and significant disparities in care exist in these communities.
The National Kidney Foundation (NKF) is introducing a Collective Impact strategy to develop and advance equitable strategies to improve CKD testing and diagnosis in primary care. The Ending Disparities Summit will convene stakeholders to participate in a series of “Learning in Action” meetings. During these meetings participants will:
- Analyze the prevalence of undiagnosed chronic kidney disease (CKD) in Virginia and DC, and its impact on patient outcomes, healthcare costs and health inequities.
- Discuss strategies and approaches that can be employed to improve CKD recognition and care in primary care settings
- Evaluate the impact the new Kidney Health Evaluation HEDIS measure can have on improving breakdowns in care and develop a strategy to streamline CKD testing in primary care from a policy and payment perspective
- Develop a strategy to incorporate CKD testing and diagnosis into community wellness and prevention practices
- Develop strategies to advance CKD awareness through community engagement and to ensure that health care providers are aware of the community resources available to delay CKD progression
From these Learning in Action meetings, NKF and partners will develop a road map to drive a cultural shift in primary care — toward increasing the early diagnosis and management of CKD, especially in communities where the burden of CKD is felt most acutely. This strategy will be shared at a final stakeholders’ summit, to be held in Fall 2022.